EGFR and cancer: In this study, we assessed the biological effects of Q276P/R326Q polymorphisms on CD148's activity to suppress cancer cell proliferation and EGFR signaling by stably introducing wild‐type (WT) or mutated (Q276P/R326Q) CD148 to A431D epidermoid cancer cells that lack endogenous CD148 expression.